NCT07481110

Brief Summary

The goal of this observational study is to describe the demographic, epidemiological, clinical, and outcome characteristics of patients with gastric cancer. It also aims to analyze the diagnostic approaches and management strategies used in the care of these patients in Algeria.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
2mo left

Started Aug 2025

Shorter than P25 for all trials

Geographic Reach
1 country

15 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress86%
Aug 2025Aug 2026

Study Start

First participant enrolled

August 5, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 4, 2025

Completed
7 months until next milestone

First Posted

Study publicly available on registry

March 18, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 5, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 5, 2026

Last Updated

March 27, 2026

Status Verified

September 1, 2025

Enrollment Period

1 year

First QC Date

September 4, 2025

Last Update Submit

March 25, 2026

Conditions

Keywords

Gastric CancerGastric cancer in Algerian patientsObservational studyPatient outcomesOncologyRetrospective dataTreatment strategiesDiagnostic approachesClinical characteristicsEpidemiological dataDemographic dataCross-sectional studyReal-world dataAlgeriaAlgerian Study

Outcome Measures

Primary Outcomes (5)

  • Demographic characteristics of patients with gastric cancer in Algeria

    The patient's demographic profile will include age (years) and sex. Body Mass Index (BMI) will be calculated using weight (kg) and height (m) according to the formula BMI = weight / height² (kg/m²).

    At Baseline ( Initial visit )

  • Sociological characteristics of patients with gastric cancer in Algeria

    The patient's sociological profile will be described as a composite variable : Education level (primary, secondary, university, other), Profession (employed, unemployed, retired, student, other), Place of residence (current residence; urban or rural), Origin (wilaya of birth/origin)

    At Baseline ( Initial visit )

  • Epidemiological characteristics of patients with gastric cancer in Algeria.

    Frequency (%) of epidemiological risk factors including family history of cancer, Helicobacter pylori infection, smoking status, alcohol consumption, dietary habits, and exposure to chemical substances.

    At Baseline (Initial Visit)

  • Clinical characteristics of patients with gastric cancer in Algeria.

    Distribution of patients according to initial symptoms, tumor localization, histological characteristics, biomarker expression, presence of metastases, and tumor stage according to the AJCC classification.

    At Basline ( Initial Visit)

  • Evolutionary characteristics of patients with gastric cancer.

    Distribution of treatment modalities including surgery (palliative or curative) and chemotherapy (adjuvant or treatment lines), as well as treatment response, complications, disease-free survival (DFS), and duration of response.

    At Baseline ( Initial Visit)

Secondary Outcomes (2)

  • Diagnostic modalities in patients with gastric cancer in Algeria

    At Basline (Initial Visit)

  • Therapeutic management modalities

    At Baseline (Initial Visit)

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with histologically confirmed gastric cancer, followed in the participating oncology departments.

You may qualify if:

  • Patients aged 19 years and older
  • Histologically confirmed diagnosis of gastric cancer
  • Patients followed in the participating oncology departments
  • Informed consent obtained
  • Histological types other than carcinoma (e.g., GIST, lymphoma, sarcoma, etc.).
  • Secondary gastric tumors
  • Participation in an interventional study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (15)

Cac Blida

Algiers, Algeria, 16000, Algeria

NOT YET RECRUITING

CHU Béni Messous

Algiers, Algeria, 16000, Algeria

RECRUITING

CPMC

Algiers, Algeria

NOT YET RECRUITING

EPH Rouiba

Algiers, Algeria

NOT YET RECRUITING

CHU Annaba

Annaba, Algeria

NOT YET RECRUITING

CHU Constantine

Constantine, Algeria

NOT YET RECRUITING

EPH Constantine

Constantine, Algeria

NOT YET RECRUITING

CAC Oued Souf

El Oued, Algeria

NOT YET RECRUITING

CAC Oran

Oran, Algeria

NOT YET RECRUITING

CHU Oran

Oran, Algeria

NOT YET RECRUITING

EHU Oran

Oran, Algeria

NOT YET RECRUITING

CAC Sétif

Sétif, Algeria

NOT YET RECRUITING

CAC Sidi Bel Abbès

Sidi Bel Abbes, Algeria

NOT YET RECRUITING

EPH Sidi Ghiles

Tipasa, Algeria

NOT YET RECRUITING

CAC DBK

Tizi Ouzou, Algeria

NOT YET RECRUITING

MeSH Terms

Conditions

Stomach NeoplasmsDiseaseNeoplasms

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteDigestive System DiseasesGastrointestinal DiseasesStomach DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 4, 2025

First Posted

March 18, 2026

Study Start

August 5, 2025

Primary Completion (Estimated)

August 5, 2026

Study Completion (Estimated)

August 5, 2026

Last Updated

March 27, 2026

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations